|
Genetic Studies of Lupus Clinical Trials Information presented on Clinical Trials Search is not designed to be a substitute for proven healthcare advice, travels to or treatment by using a genuine medical doctor. We are not physicians. Always confer with your doctor on Genetic Studies of Lupus conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. Genetic Studies of Lupus Clinical research trials and Genetic Studies of Lupus healthcare trials take place in many of cities across the United States of America. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally evaluate the effectiveness of new drugs. The function of the studies / undertakings is to answer specific human medical questions. Clinical trials are a popular means for mDs, government agencies, and private sector companies to find treatments for all forms of conditions, including Genetic Studies of Lupus. Genetic Studies of Lupus Clinical Trials and other clinical trials allow for volunteers to access medical treatment alternatives before they are available to the masses. Many times the test subjects undergo treatment for without cost, and occasionally they are compensated for their time. Occasionally there is a cost for a Genetic Studies of Lupus clinical trial. Test subjects oftentimes recieve the best healthcare possible for their Genetic Studies of Lupus condition. Hazards are a reality, nonetheless, and might include additional or frequent doctor trips, healthcare hazards (perhaps life-jeopardizing), and/or the treatment being ineffective. Trials are federally regulated with rigid guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "G" Clinical Trials Conditions > Genetic Studies of Lupus  Genetic Studies of Lupus
Genetic Studies of Lupus
For Condition: Systemic Lupus Erythematosus
Status: Recruiting
Sponsor(s): National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) ,
Synopsis: The Lupus Genetic Linkage Study and Lupus Multiplex Registry & Repository are working to find the genes that cause systemic lupus erythematosus (SLE, or lupus). The study is enrolling families of all ethnic backgrounds from the United States, Canada, Puerto Rico, and the Virgin Islands that have two or more living members diagnosed with SLE.
Details: SLE is an often crippling and potentially fatal autoimmune disease that is nine times more prevalent in women than in men, and four times more likely to affect African American females than Caucasian females. It is suspected that a genetic predisposition along with environmental factors contribute to the clinical manifestation of SLE. The Lupus Multiplex Registry & Repository is the largest repository of its kind in North America. In addition to the research done on site, the Repository serves as a national resource for scientists interested in conducting research on SLE and lupus multiplex families. Data, serum samples, and DNA samples are available to researchers. By collecting pedigrees in which two or more living individuals have been diagnosed with SLE, the study is utilizing the genetic link between the affected family members to discover disease-associated genes. Records will be requested from the patients' treating physicians to document various lupus symptoms and related problems. One-time blood samples will be collected from the patients as well as from certain family members and an unrelated volunteer. There is no cost to participate and the study pays for sample draws and shipping.
Eligibility:
Study Type: Observational, Natural History, Longitudinal, Defined Population, Retrospective/Prospective Study
Minimum Age/Maximum Age: /
Genders: Both
Protocol Entry Criteria: Inclusion Criteria: - Families in which two or more living members have been diagnosed with systemic lupus erythematosus - Live in the United States, Canada, Puerto Rico, or the Virgin Islands
Total Enrollment:
Location and Contact Information:
Overall Study Official:
JohnHarley, Principal Investigator, Member & Program Head, Arthritis and Immunology Research Program; Oklahoma Medical Research Foundation
Oklahoma Medical Research Foundation *Recruiting*
Oklahoma City, Oklahoma, 73104
United States
Recruiting Recruiters 888-655-8787
Additional Information:
Study ID Numbers: NIAMS-102;
Study Start Date: October 1995
Record last reviewed: March 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00071175
Other Systemic Lupus Erythematosus Studies:
1. Safety and Efficacy Study of LJP 394 (abetimus sodium) to treat lupus kidney disease
2. Study of Families with Twins or Siblings Discordant for Rheumatic Disorders
3. Cyclophosphamide and Fludarabine to Treat Lupus Nephritis
4. Pilot Study of Cyclophosphamide in Patients With Life-Threatening Systemic Lupus Erythematosus or Antiphospholipid Antibody Syndrome
5. Psychoeducational Approach to Improve Health in Lupus
Related Studies:
Other Systemic Lupus Erythematosus Clinical Trials
Other Oklahoma Clinical Trials
Other Oklahoma City Clinical Trials
Genetic Studies of Lupus
|
|
|
|
|
|
|
|
